nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—PTK2B—Alpha-synuclein signaling—UCHL1—gallbladder cancer	0.202	0.202	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—gallbladder cancer	0.042	0.042	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.0409	0.0409	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.0373	0.0373	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.0373	0.0373	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.0352	0.0352	CbGpPWpGaD
Leflunomide—PTK2B—IL-2 Signaling Pathway—BCL2—gallbladder cancer	0.0327	0.0327	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.0299	0.0299	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—BCL2—gallbladder cancer	0.0267	0.0267	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—NRAS—gallbladder cancer	0.0221	0.0221	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.0214	0.0214	CbGpPWpGaD
Leflunomide—PTK2B—Signaling of Hepatocyte Growth Factor Receptor—HRAS—gallbladder cancer	0.0209	0.0209	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—NRAS—gallbladder cancer	0.0197	0.0197	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—KRAS—gallbladder cancer	0.019	0.019	CbGpPWpGaD
Leflunomide—PTK2B—IL-2 Signaling Pathway—HRAS—gallbladder cancer	0.0177	0.0177	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—KRAS—gallbladder cancer	0.017	0.017	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—HRAS—gallbladder cancer	0.0161	0.0161	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—EGFR—gallbladder cancer	0.0157	0.0157	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—KRAS—gallbladder cancer	0.0147	0.0147	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—HRAS—gallbladder cancer	0.0144	0.0144	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.0144	0.0144	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.0136	0.0136	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—TP53—gallbladder cancer	0.013	0.013	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—HRAS—gallbladder cancer	0.0128	0.0128	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—HRAS—gallbladder cancer	0.0126	0.0126	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—HRAS—gallbladder cancer	0.0125	0.0125	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.0121	0.0121	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—NRAS—gallbladder cancer	0.0114	0.0114	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—NRAS—gallbladder cancer	0.0113	0.0113	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—NRAS—gallbladder cancer	0.0108	0.0108	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.0108	0.0108	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.0104	0.0104	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	0.00983	0.00983	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—KRAS—gallbladder cancer	0.00976	0.00976	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—TP53—gallbladder cancer	0.00962	0.00962	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—HRAS—gallbladder cancer	0.0096	0.0096	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—KRAS—gallbladder cancer	0.00928	0.00928	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—KEAP1—gallbladder cancer	0.00882	0.00882	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.00836	0.00836	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—HRAS—gallbladder cancer	0.0083	0.0083	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—HRAS—gallbladder cancer	0.00789	0.00789	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.00747	0.00747	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.00706	0.00706	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—HRAS—gallbladder cancer	0.00659	0.00659	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.006	0.006	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00529	0.00529	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00456	0.00456	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.0045	0.0045	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ERBB4—gallbladder cancer	0.00419	0.00419	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.0041	0.0041	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.0041	0.0041	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00388	0.00388	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.00387	0.00387	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ERBB3—gallbladder cancer	0.00362	0.00362	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.0033	0.0033	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ERBB4—gallbladder cancer	0.00271	0.00271	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ERBB3—gallbladder cancer	0.00234	0.00234	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BCL2—gallbladder cancer	0.00234	0.00234	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ERBB2—gallbladder cancer	0.00227	0.00227	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NRAS—gallbladder cancer	0.00173	0.00173	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—EGFR—gallbladder cancer	0.00157	0.00157	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—KRAS—gallbladder cancer	0.00149	0.00149	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ERBB2—gallbladder cancer	0.00147	0.00147	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HRAS—gallbladder cancer	0.00126	0.00126	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NRAS—gallbladder cancer	0.00112	0.00112	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EGFR—gallbladder cancer	0.00102	0.00102	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KRAS—gallbladder cancer	0.000962	0.000962	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—gallbladder cancer	0.000855	0.000855	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HRAS—gallbladder cancer	0.000818	0.000818	CbGpPWpGaD
